Hims & Hers Health
HIMS
297 hedge funds and large institutions have $2.75B invested in Hims & Hers Health in 2024 Q2 according to their latest regulatory filings, with 98 funds opening new positions, 109 increasing their positions, 63 reducing their positions, and 41 closing their positions.
139% more first-time investments, than exits
New positions opened: 98 | Existing positions closed: 41
86% more call options, than puts
Call options by funds: $266M | Put options by funds: $143M
73% more repeat investments, than reductions
Existing positions increased: 109 | Existing positions reduced: 63
39% more capital invested
Capital invested by funds: $1.97B → $2.75B (+$774M)
22% more funds holding
Funds holding: 244 → 297 (+53)
3.92% more ownership
Funds ownership: 61.97% → 65.89% (+3.9%)
33% less funds holding in top 10
Funds holding in top 10: 9 → 6 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$61.8M |
| 2 |
Renaissance Technologies
New York
|
+$53.3M |
| 3 |
JP Morgan Chase
New York
|
+$37.2M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$36M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$34.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RM
Redpoint Management
Woodside,
California
|
-$78.5M |
| 2 |
NCPI
NewView Capital Partners I
Burlingame,
California
|
-$60.9M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$57.1M |
| 4 |
IVMX
Institutional Venture Management XV
Menlo Park,
California
|
-$43.7M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$27.7M |
HIMS Hedge Fund Activity: Q2 2024 in Review
297 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Hims & Hers Health (HIMS) for Q2 2024, worth a combined $2.75B — up 39% from $1.97B a quarter earlier.
Buyers outnumbered sellers: 98 funds opened new HIMS positions and 41 closed out — a net gain of 57 holders — while 109 added to existing stakes and 63 trimmed.
The largest buyer was BlackRock, adding an estimated $61.8M. The largest seller was Redpoint Management, exiting entirely with an estimated $78.5M sold.
- 297 institutional investors held Hims & Hers Health (HIMS) as of Q2 2024, up from 244 in Q1 2024.
- Funds reported $2.75B of Hims & Hers Health stock for Q2 2024, up 39% quarter-over-quarter.
- 98 funds opened new Hims & Hers Health positions in Q2 2024 and 41 closed out, a net change of +57 holders.
- The largest Hims & Hers Health buyer in Q2 2024 was BlackRock, an estimated $61.8M added.
- The largest Hims & Hers Health seller in Q2 2024 was Redpoint Management, an estimated $78.5M sold.
Based on aggregated 13F filings for Q2 2024.